Weernink E E, Huisman A B, van Baarlen J, ten Napel C H
Department of Internal Medicine, Medisch Spectrum Twente, Enschede, Netherlands.
Eur J Gastroenterol Hepatol. 1996 Jan;8(1):85-8. doi: 10.1097/00042737-199601000-00016.
Budd-Chiari syndrome is a rare disease and, with or without treatment, the prognosis is usually poor. Percutaneous transluminal angioplasty of the hepatic vein in Budd-Chiari syndrome is a safe method, although recurrent stenosis makes it necessary to repeat it several times in most cases. Insertion of a wall-stent in the hepatic vein seems to be a more long-lasting treatment. Monitoring the blood flow through the wall-stent every 6 months is important because of the apparent obliteration of the wall-stent by intimal fibrosis of the hepatic vein. Further follow-up investigations of this method are necessary.
布加综合征是一种罕见疾病，无论是否接受治疗，其预后通常都很差。布加综合征经皮肝静脉腔内血管成形术是一种安全的方法，尽管复发性狭窄使得大多数情况下有必要多次重复该操作。在肝静脉中置入壁式支架似乎是一种更持久的治疗方法。由于肝静脉内膜纤维化明显导致壁式支架闭塞，每6个月监测通过壁式支架的血流很重要。有必要对该方法进行进一步的随访研究。
